Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
2020 · Cell · 1,081 citations
https://doi.org/10.1016/j.cell.2020.11.020
K
Kathleen A. Williamson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
10.8K
Citations
43
h-index
62
i10-index
Kathleen A. Williamson is an academic researcher from Institute of Genetics and Cancer. The author has contributed to research in topics: Ocular Disorders and Treatments & SARS-CoV-2 and COVID-19 Research & Congenital Ear and Nasal Anomalies. The author has an h-index of 43, co-authored 77 publications.
ORCID: 0000-0001-7223-439XPapers by this author
worksRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
2021 · Cell Reports · 446 citations
https://doi.org/10.1016/j.celrep.2021.109292
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
2021 · The Lancet Public Health · 339 citations
https://doi.org/10.1016/s2468-2667(21)00055-4
Genetic Analysis of ‘PAX6-Negative’ Individuals with Aniridia or Gillespie Syndrome
2016 · PLoS ONE · 85 citations
https://doi.org/10.1371/journal.pone.0153757
The genetic architecture of aniridia and Gillespie syndrome
2018 · Human Genetics · 76 citations
https://doi.org/10.1007/s00439-018-1934-8
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
2014 · Nature Communications · 74 citations
https://doi.org/10.1038/ncomms5871
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat